Atypical antipsychotics and cardiovascular risk in schizophrenic patients

被引：21

作者：

Bouchard, RH ^{[1
]}

Demers, MF

Simoneau, I

Alméras, N

Villeneuve, J

Mottard, JP

Cadrin, C

Lemieux, I

Després, JP

机构：

[1] Univ Laval Robert Giffard, Ctr Rech, Polyclin St Anne, Quebec City, PQ, Canada

[2] Ctr Rech Malad Lipidiques, Quebec City, PQ, Canada

[3] Ctr Hosp Albert Prevost, Quebec City, PQ, Canada

[4] Ctr Hosp Robert Giffard, Quebec City, PQ, Canada

来源：

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2001年 / 21卷 / 01期

关键词：

D O I：

10.1097/00004714-200102000-00021

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：110 / 111

页数：2

共 20 条

[1]

Allison DB, 1999, AM J PSYCHIAT, V156, P1686

[2] Longitudinal comparative study of risperidone and conventional neuroleptics for treating patients with schizophrenia [J].

Bouchard, RH ;

Mérette, C ;

Pourcher, E ;

Demers, MF ;

Villeneuve, J ;

Roy-Gagnon, MH ;

Gauthier, Y ;

Cliche, D ;

Labelle, A ;

Filteau, MJ ;

Roy, MA ;

Maziade, M .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (03) :295-304

[3] Diabetic ketoacidosis associated with clozapine treatment [J].

Colli, A ;

Cocciolo, M ;

Francobandiera, G ;

Rogantin, F ;

Cattalini, N .

DIABETES CARE, 1999, 22 (01) :176-177

[4] REGIONAL DISTRIBUTION OF BODY-FAT, PLASMA-LIPOPROTEINS, AND CARDIOVASCULAR-DISEASE [J].

DESPRES, JP ;

MOORJANI, S ;

LUPIEN, PJ ;

TREMBLAY, A ;

NADEAU, A ;

BOUCHARD, C .

ARTERIOSCLEROSIS, 1990, 10 (04) :497-511

[5] Diabetic ketoacidosis with olanzapine treatment [J].

Gatta, B ;

Rigalleau, V ;

Gin, H .

DIABETES CARE, 1999, 22 (06) :1002-1003

[6]

Gaulin BD, 1999, AM J PSYCHIAT, V156, P1270

[7] Serum triglyceride levels in patients treated with clozapine [J].

Ghaeli, P ;

Dufresne, RL .

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (17) :2079-2081

[8]

Goldman LS, 1999, J CLIN PSYCHIAT, V60, P10

[9] New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment [J].

Goldstein, LE ;

Sporn, J ;

Brown, S ;

Kim, H ;

Finkelstein, J ;

Gaffey, GK ;

Sachs, G ;

Stern, TA .

PSYCHOSOMATICS, 1999, 40 (05) :438-443

[10] Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease [J].

Lamarche, B ;

Tchernof, A ;

Mauriège, P ;

Cantin, B ;

Dagenais, GR ;

Lupien, PJ ;

Després, JP .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (24) :1955-1961

← 1 2 →